Scott+Scott Secures Final Settlement Approval in Class Action Against Walgreen Co.
NEW YORK — Scott+Scott Attorneys at Law, along with co-counsel, has secured final court approval of a $100 million settlement in a class action against Walgreens on behalf of a class of consumers and third-party payors alleging unlawful overcharges for medically necessary prescription drugs. The settlement resolves a long-running case, first filed in March 2017 in the United States District Court for the Northern District of Illinois, and covers purchases of prescription drugs from January 2007 to November 2024.
In approving the settlement, the Court noted that class counsel had litigated the case for seven years and was familiar with factual and legal hurdles. The Court further noted that the settlement was the result of several months of negotiations between counsel for both sides following the expenditure of a considerable amount of time and resources in pursuing a recovery for the class.
Scott+Scott Partner Jospeh P. Guglielmo stated: “Prescription drug costs are a major issue impacting consumers and third-party payors throughout the United States. We are pleased that the Court granted final approval of this monumental settlement, which will provide substantial benefits to those who paid for prescription drugs in excess of Walgreens’ PSC prices.”
The case is: Forth v. Walgreen Co., No. 1:17-cv-02246 (N.D. Ill.) and the Scott+Scott team attorneys included: Partners Joseph P. Guglielmo and Erin Green Comite as well as attorneys from co-lead class counsel Robbins Geller Rudman & Dowd .